Evidence map›Paper›PMID 41924163›Full record

ArticleInfection and drug resistance2026

The Evolving Triad of Carbapenem Resistance: Emergence of Dominant CRPA, Persistent CRAB, and Rebounding CRKP in a Chinese Regional Hospital (2020-2024).

Kaixuan Zhang, Mengyu Zhang, Henggui Hu, Shuguo Qin, Huihui Li, Pingping Zhao, Yuanyuan Xu, Sudi Zhu

Abstract read
In one paragraph

Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kaixuan Zhang *Department of Clinical Laboratory, Wanbei Coal-Electricity Group General Hospital, Suzhou, People's Republic of China.
Mengyu Zhang *Department of Clinical Laboratory, Wanbei Coal-Electricity Group General Hospital, Suzhou, People's Republic of China.
Henggui HuDepartment of Clinical Laboratory, Wanbei Coal-Electricity Group General Hospital, Suzhou, People's Republic of China.
Shuguo QinDepartment of Clinical Laboratory, Wanbei Coal-Electricity Group General Hospital, Suzhou, People's Republic of China.
Huihui LiDepartment of Clinical Laboratory, Wanbei Coal-Electricity Group General Hospital, Suzhou, People's Republic of China.
Pingping ZhaoDepartment of Clinical Laboratory, Wanbei Coal-Electricity Group General Hospital, Suzhou, People's Republic of China.
Yuanyuan XuDepartment of Clinical Laboratory, Wanbei Coal-Electricity Group General Hospital, Suzhou, People's Republic of China.
Sudi Zhu *Department of Clinical Laboratory, Wanbei Coal-Electricity Group General Hospital, Suzhou, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Carbapenem-resistant Gram-negative bacteria (CR-GNB) represent a critical threat in healthcare settings. However, their evolving epidemiology in regional hospitals remains poorly understood. We aimed to delineate the resistance trends and risk factors of CR-GNB in a Chinese regional hospital to guide infection control. Patients and Methods: We conducted a retrospective epidemiological study from 2020 to 2024. A total of 148,622 clinical specimens were collected, yielding 19,264 culture-positive isolates. We examined microbial distribution and carbapenem resistance (CR) rates. Multivariable logistic regression was used to identify independent risk factors for CR-GNB infection. Results: The overall culture positivity rate was 12.96%. Gram-negative bacilli accounted for 71.7% of the positive isolates. CR analysis revealed a critical shift: Conclusion: Our findings reveal a critical shift in the CR-GNB landscape, characterized by the emergence of dominant CRPA alongside persistent CRAB and rebounding CRKP. This "Evolving Triad", entrenched in ICUs, underscores the urgent need for "Proactive Ecological Intervention" strategies. This study provides a crucial epidemiological baseline for regional hospitals.

Indexed as

carbapenem resistanceepidemiologygram-negative bacteriaintensive care unitrisk factors

Identifiers

PMID41924163
PMCPMC13038037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.